Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy
This review summarizes prior data regarding adjuvant and neo-adjuvant chemotherapy in non-small cell lung cancer and elaborates on results from the newer trials